Vor Biopharma
VOR
VOR
58 hedge funds and large institutions have $400M invested in Vor Biopharma in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
72.83% more ownership
Funds ownership: 82.86% → 155.69% (+73%)
21% more funds holding
Funds holding: 48 → 58 (+10)
Holders
58
Holding in Top 10
6
Calls
$217K
Puts
$42K
Top Buyers
| 1 | +$77.3M | |
| 2 | +$31.8M | |
| 3 | +$31.5M | |
| 4 |
AG
Artal Group
Luxembourg
|
+$15.5M |
| 5 |
LCM
Laurion Capital Management
New York
|
+$15.5M |
Top Sellers
| 1 | -$1.33M | |
| 2 | -$1.02M | |
| 3 | -$282K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$138K |
| 5 |
Goldman Sachs
New York
|
-$76K |